Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Sen A. et al, (2021), Trials, 22

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.

Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Raman B. et al, (2021), EClinicalMedicine

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.

Raman B. et al, (2021), EClinicalMedicine, 31

Evaluation of [13N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.

Egerton A. et al, (2020), EJNMMI Res, 10

Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database.

Koychev I. et al, (2020), BMJ Open, 10

Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study.

Calvin CM. et al, (2020), Alzheimers Res Ther, 12

Blood-based ATN biomarkers of Alzheimer’s disease: A meta-analysis

KOYCHEV I. et al, (2020), Journal of Alzheimer's Disease

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.

Koychev I. et al, (2020), J Nucl Med, 61, 1413 - 1418

Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study.

Vaci N. et al, (2020), Br J Psychiatry, 1 - 7

Evaluating the Feasibility of Frequent Cognitive Assessment Using the Mezurio Smartphone App: Observational and Interview Study in Adults With Elevated Dementia Risk (Preprint)

Lancaster C. et al, (2020), JMIR Mhealth Uhealth

Real-World Effectiveness, Its Predictors and Onset of Action of Cholinesterase Inhibitors and Memantine in Dementia: A Retrospective Health Record Study of 7400 Individuals using the UK CRIS Platform

KOYCHEV I. et al, (2020), British Journal of Psychiatry

The Dementias Platform UK (DPUK) Data Portal.

Bauermeister S. et al, (2020), Eur J Epidemiol, 35, 601 - 611

Gallery Game: Smartphone-based assessment of long-term memory in adults at risk of Alzheimer's disease.

Lancaster C. et al, (2020), J Clin Exp Neuropsychol, 42, 329 - 343

The Mezurio smartphone application: Evaluating the feasibility of frequent digital cognitive assessment in the PREVENT dementia study

Lancaster C. et al, (2020), JMIR mHealth and uHealth

Evaluating the Feasibility of Frequent Cognitive Assessment Using the Mezurio Smartphone App: Observational and Interview Study in Adults With Elevated Dementia Risk.

Lancaster C. et al, (2020), JMIR Mhealth Uhealth, 8

Alzheimer's Disease

GALLACHER J. and KOYCHEV I., (2020), New Oxford Textbook of Psychiatry, 395 - 404

Prediction of rapid amyloid and phosphorylated‐Tau accumulation in cognitively healthy individuals.

Koychev I. et al, (2020), Alzheimers Dement (Amst), 12

Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study.

Henshall C. et al, (2019), Evid Based Ment Health, 22, 56 - 60

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

Koychev I. et al, (2019), BMJ Open, 9

Load More

Include forthcoming?